Pfizer, BioNTech Covid-19 Vaccine 90% Effective in Interim Analysis of Phase 3 Trial, Companies Say. This news made gold market down.
Pfizer/BioNTech: Experimental Vaccine Found To Be Over 90% Effective In Preventing Covid-19
Pfizer/BioNTech: Plans To Seek US Emergency Use Authorization Soon After Safety Milestone Is Reached In Late November
-Expects Trial Will Reach Final Analysis Point Of 164 Infections By First Or Second Week Of December
Pfizer/BioNTech:
-Expects To Produce Up To 50 Million Doses Of Covid-19 Vaccine In 2020
-Expects To Produce Up To 1.3 Billion Doses Of Covid-19 Vaccine In 2021
If you follow our live tweet page, you will see this news fast, our live tweet page covered it when Gold was $1945
Tags: Fundamental Analysis